News & Insights

Noetik Announces First-in-Class Human Foundation Models for Discovery at SITC 2024

By

Noetik

Business Wire

November 8, 2024

Noetik Selected to Participate in the 2024 AWS Generative AI Accelerator

By

Noetik

Business Wire

September 12, 2024

Noetik Secures $40 Million Series A Financing to Advance Precision Cancer Therapies

By

Noetik

Business Wire

August 29, 2024

Exclusive: Noetik raises $40M Series A to advance AI ambitions in cancer - with an unlikely lead investor

By

Andrew Dunn

Endpoints News

August 28, 2024

Noetik Appoints Dr. Shafique Virani as Chief Business Officer

By

Noetik

Business Wire

Noetik Launches "Perturb-map" In Vivo Functional Genomics Platform and Adds Precision Immunology Leader Brian Brown, Ph.D. to Scientific Advisory Board

By

Noetik

Business Wire

November 15, 2023

NOETIK: A New Foundation for Cancer

By

Dylan Reid

Zetta

September 15, 2023

Spatial Biology and AI Combined by Noetik to Develop Immuno-Oncology Drugs

By

Julianna LeMieux, PhD

GEN

September 11, 2023

Exclusive: Two ex-Recursion leaders start Noetik in a bid to fix the broken funnel in cancer drug research

By

Andrew Dunn

Endpoints News

September 7, 2023

Recursion Vets Unveil Startup Noetik, Using AI to Unlock Tumor Biology

By

Frank Vinluan

MedCity News

September 7, 2023

DCVC Leads $14 Million Seed Round for Noetik

By

James Hardiman

DCVC

September 7, 2023